COVID‐19 outbreak as a probable cause of increased risk of intracranial rebleeding in partially treated cerebral arteriovenous malformations
Abstract Patients who are infected with COVID‐19 and have cerebral arteriovenous malformations which are partially treated or untreated may be more liable to rupture or bleed than not infected patients.
Guardado en:
Autores principales: | Mohammad Ghorbani, Ghazwan Lafta, Farhad Rahbarian |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/533376819d2940eaad85cec8859ec3f7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
THE EFFECT OF HYPOXIC BRAIN DAMAGE ON THE SURVIVAL OF PREMATURE INFANTS
por: N. V. Likholetova, et al.
Publicado: (2018) -
Impact of a “Brain Protection Bundle” in Reducing Severe Intraventricular Hemorrhage in Preterm Infants <30 Weeks GA: A Retrospective Single Centre Study
por: Nishkal Persad, et al.
Publicado: (2021) -
Characterization of Endothelial Cells Associated with Cerebral Arteriovenous Malformation
por: Jia YC, et al.
Publicado: (2020) -
Heron-mouth neuroendoscopic sheath-assisted neuroendoscopy plays critical roles in treating hypertensive intraventricular hemorrhage
por: Jie Xu, et al.
Publicado: (2020) -
Cerebral Arteriovenous Malformation Treatment by Full Transcranial Neuroendoscopic Approaches
por: Cai Q, et al.
Publicado: (2020)